Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$16.27
+2.0%
$14.85
$10.05
▼
$17.35
$28.86B0.08102,501 shs60,038 shs
Shiseido Co. stock logo
SSDOY
Shiseido
$24.03
+1.6%
$22.18
$13.60
▼
$24.06
$9.45B0.2763,517 shs50,737 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
+2.01%+7.46%+6.90%+19.19%+53.61%
Shiseido Co. stock logo
SSDOY
Shiseido
+1.55%+8.06%+7.99%+20.14%+33.65%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$16.27
+2.0%
$14.85
$10.05
▼
$17.35
$28.86B0.08102,501 shs60,038 shs
Shiseido Co. stock logo
SSDOY
Shiseido
$24.03
+1.6%
$22.18
$13.60
▼
$24.06
$9.45B0.2763,517 shs50,737 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
+2.01%+7.46%+6.90%+19.19%+53.61%
Shiseido Co. stock logo
SSDOY
Shiseido
+1.55%+8.06%+7.99%+20.14%+33.65%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
2.50
Moderate BuyN/AN/A
Shiseido Co. stock logo
SSDOY
Shiseido
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$14.21B2.07$2.28 per share7.14$6.36 per share2.56
Shiseido Co. stock logo
SSDOY
Shiseido
$6.49B1.48$1.28 per share18.78$9.93 per share2.42
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$1.83B$1.3112.3812.33N/A16.01%25.79%12.87%11/4/2026 (Estimated)
Shiseido Co. stock logo
SSDOY
Shiseido
-$259.66M-$0.4060.6726.700.94-2.39%4.06%2.01%11/9/2026 (Estimated)

Latest SSDOY and ALPMY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026N/A
Shiseido Co. stock logo
SSDOY
Shiseido
$0.1122N/AN/AN/A$1.48 billionN/A
11/4/2026N/A
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$0.4113N/AN/AN/A$3.79 billionN/A
8/5/2026Q2 2026
Shiseido Co. stock logo
SSDOY
Shiseido
$0.2090$0.33+$0.1210$0.33$1.61 billion$1.69 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
$0.291.78%N/A22.14%N/A
Shiseido Co. stock logo
SSDOY
Shiseido
$0.271.12%N/AN/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
0.16
1.20
0.93
Shiseido Co. stock logo
SSDOY
Shiseido
0.37
1.38
0.94

Institutional Ownership

CompanyInstitutional Ownership
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
N/A
Shiseido Co. stock logo
SSDOY
Shiseido
0.02%

Insider Ownership

CompanyInsider Ownership
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
N/A
Shiseido Co. stock logo
SSDOY
Shiseido
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Astellas Pharma Inc. stock logo
ALPMY
Astellas Pharma
14,0991.81 billionN/ANot Optionable
Shiseido Co. stock logo
SSDOY
Shiseido
26,330399.53 millionN/ANot Optionable

Recent News About These Companies

Shiseido Company Ltd ADR (SSDOY)
Jefferies Remains a Buy on Shiseido Company,Limited (4911)
Shiseido Company,Limited (4911) Gets a Buy from Goldman Sachs
Shiseido Co. Ltd. ADR
Shiseido Co Ltd ADR SSDOY
Shiseido Surges 15% After 61.4% Profit Jump, Forecast Beats
Shiseido Americas to Slash Workforce as Sales Plummet
Layoffs Hit Shiseido Americas
Shiseido Americas to make ‘significant’ job cuts

Media Sentiment Over Time

Astellas Pharma stock logo

Astellas Pharma OTCMKTS:ALPMY

$16.27 +0.32 (+2.01%)
As of 10/26/2026 03:59 PM Eastern

Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.

Shiseido stock logo

Shiseido OTCMKTS:SSDOY

$24.03 +0.37 (+1.55%)
As of 10/26/2026 03:59 PM Eastern

Shiseido Company, Limited engages in the production and sale of cosmetics in Japan and internationally. The company offers fragrances; and skincare and makeup products. It also engages in the restaurant and food, and retail businesses; and operates beauty salons. In addition, the company operates and supports SABFA, a professional hair makeup training school. Further, it offers childcare facilities. The company sells its products through department, specialized cosmetic, drug, and general merchandise stores. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.